Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Verheijen

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
The Journal of Allergy and Clinical Immunology|November 28, 2019
Defining a new immune deficiency syndrome: MAN2B2-CDGJan Verheijen, Sunnie Y Wong, Jared H Rowe, et al.
American Journal of Human Genetics|April 16, 2019
The Metabolic Map into the Pathomechanism and Treatment of PGM1-CDGSilvia Radenkovic, Matthew J Bird, Tim L Emmerzaal, et al.
BMC Medical Genomics|November 14, 2025
RNA sequencing provides functional insights and diagnostic resolution in previously unsolved rare disease casesRobert G Lewis, John M O'Shea, Lucilla Pizzo, et al.
Acta Neuropathologica|March 31, 2016
A comprehensive study of the genetic impact of rare variants in SORL1 in European early-onset Alzheimer's diseaseJan Verheijen, Tobi Van den Bossche, Julie van der Zee, et al.
Neurobiology of Aging|November 18, 2017
Common and rare TBK1 variants in early-onset Alzheimer disease in a European cohortJan Verheijen, Julie van der Zee, Ilse Gijselinck, et al.
Brain : a Journal of Neurology|June 17, 2024
De novo and inherited monoallelic variants in TUBA4A cause ataxia and spasticityMehdi Benkirane, Marion Bonhomme, Heba Morsy, et al.
American Journal of Human Genetics|March 26, 2025
Consensus guidelines for assessing eligibility of pathogenic DNA variants for antisense oligonucleotide treatmentsDavid Cheerie, Margaret M Meserve, Danique Beijer, et al.
Acta Neuropathologica|April 28, 2017
Deleterious ABCA7 mutations and transcript rescue mechanisms in early onset Alzheimer's diseaseArne De Roeck, Tobi Van den Bossche, Julie van der Zee, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
The Journal of Allergy and Clinical Immunology|November 28, 2019
Defining a new immune deficiency syndrome: MAN2B2-CDGJan Verheijen, Sunnie Y Wong, Jared H Rowe, et al.
American Journal of Human Genetics|April 16, 2019
The Metabolic Map into the Pathomechanism and Treatment of PGM1-CDGSilvia Radenkovic, Matthew J Bird, Tim L Emmerzaal, et al.
BMC Medical Genomics|November 14, 2025
RNA sequencing provides functional insights and diagnostic resolution in previously unsolved rare disease casesRobert G Lewis, John M O'Shea, Lucilla Pizzo, et al.
Acta Neuropathologica|March 31, 2016
A comprehensive study of the genetic impact of rare variants in SORL1 in European early-onset Alzheimer's diseaseJan Verheijen, Tobi Van den Bossche, Julie van der Zee, et al.
Neurobiology of Aging|November 18, 2017
Common and rare TBK1 variants in early-onset Alzheimer disease in a European cohortJan Verheijen, Julie van der Zee, Ilse Gijselinck, et al.
Brain : a Journal of Neurology|June 17, 2024
De novo and inherited monoallelic variants in TUBA4A cause ataxia and spasticityMehdi Benkirane, Marion Bonhomme, Heba Morsy, et al.
American Journal of Human Genetics|March 26, 2025
Consensus guidelines for assessing eligibility of pathogenic DNA variants for antisense oligonucleotide treatmentsDavid Cheerie, Margaret M Meserve, Danique Beijer, et al.
Acta Neuropathologica|April 28, 2017
Deleterious ABCA7 mutations and transcript rescue mechanisms in early onset Alzheimer's diseaseArne De Roeck, Tobi Van den Bossche, Julie van der Zee, et al.
Pageof 2